Categories
Zim Laboratories Limited — Updates, 19-05-2026: Press Release
19-05-2026 · 06:03 pm
ZIM Laboratories' European unit secured Marketing Authorization for Dabigatran Etexilate capsules in Italy. This unlocks the EU market, valued at ~$392.84 Million USD (2025), with Italy contributing ~$60.91 Million USD. Positive for commercialization.
No comments yet. Be the first to comment!